EGCG Improves Acne by Modulating Molecular Targets
কীওয়ার্ডস
বিমূর্ত
বর্ণনা
Acne vulgaris is one of the most prevalent skin disorders of sebaceous follicles, affecting more than 85% of adolescents in United States. Acne can persist throughout the adulthood, and even a mild form of acne might progress to permanent scarring on the face, chest and back, thereby causing significant physical and psychosocial morbidities. Acne is a multifactorial disease of which etiology has not been fully elucidated, although considerable progress has been made in understanding its pathogenesis during last decade. The major pathogenic features of acne include abnormal ductal keratinization, sebum overproduction, Propionibacterium acnes, and inflammation. Common acne medications such as topical retinoids, antibiotics and isotretinoin are associated with irritation and incomplete responses, increased bacterial resistance or untoward side events, respectively. Thus there is a continuing need for a novel, effective agent targeting different aspects of acne pathogenesis, with minimal side effects.
In the recent decade, epigallocatechin-3-gallate (EGCG), the major polyphenolic constituent in green tea, has attracted much interest on account of its potent anti-carcinogenic, anti-inflammatory, anti-proliferative, and antimicrobial activities. Preclinical, observational, and clinical trial data have indicated that EGCG can inhibit tumor initiation, promotion, progression, and angiogenesis. EGCG also suppresses neutrophil chemotaxis, and has been suggested to improve many diseases that have inflammatory components such as diabetes, kidney injuries, arthritis, allergies, dental caries, cardiovascular, gastrointestinal, and neurodegenerative diseases. In skin, EGCG has been investigated mainly in light of antioxidative, immunopotentiating and anticarcinogenic properties against chemicals or ultraviolet irradiation. Moreover, EGCG has lipid-lowering and antiandrogenic properties, and can downregulate peroxisome proliferator-activated receptor-γ expression. Based on these observations, it can be inferred that EGCG might be effective in the treatment of acne.
তারিখ
সর্বশেষ যাচাই করা হয়েছে: | 08/31/2012 |
প্রথম জমা দেওয়া: | 07/22/2010 |
আনুমানিক তালিকাভুক্তি জমা দেওয়া হয়েছে: | 09/12/2012 |
প্রথম পোস্ট: | 09/18/2012 |
সর্বশেষ আপডেট জমা দেওয়া হয়েছে: | 09/12/2012 |
সর্বশেষ আপডেট পোস্ট: | 09/18/2012 |
আসল অধ্যয়ন শুরুর তারিখ: | 06/30/2005 |
আনুমানিক প্রাথমিক সমাপ্তির তারিখ: | 05/31/2006 |
আনুমানিক অধ্যয়ন সমাপ্তির তারিখ: | 05/31/2006 |
অবস্থা বা রোগ
হস্তক্ষেপ / চিকিত্সা
Other: topical EGCG application on acne
পর্যায়
বাহু গ্রুপ
বাহু | হস্তক্ষেপ / চিকিত্সা |
---|---|
Active Comparator: Topical EGCG 1% Seventeen subjects were designated to use 1% EGCG .Since baseline visits, affected areas of randomly allocated half sides were treated with 1% solution twice daily, whereas those of the opposite sides were treated with vehicle only (3% ethanol). | |
Experimental: topical EGCG 5% Eighteen subjects were designated to use 5% EGCG, to evaluate a dose-response relationship. Since baseline visits, affected areas of randomly allocated half sides were treated with 5% EGCG solution twice daily, whereas those of the opposite sides were treated with vehicle only (3% ethanol). |
যোগ্যতার মানদণ্ড
বয়স অধ্যয়নের জন্য যোগ্য | 15 Years প্রতি 15 Years |
লিঙ্গ অধ্যয়নের জন্য যোগ্য | All |
স্বাস্থ্যকর স্বেচ্ছাসেবীদের গ্রহণ করে | হ্যাঁ |
নির্ণায়ক | Inclusion Criteria: - age of at least 15 years - clinical diagnosis of mild to moderate acne vulgaris Exclusion Criteria: - known pregnancy or lactation - any medical illness that might influence the results of the study, - a previous history of oral acne medication or surgical procedures including laser treatment within 6 month and topical medication within 4 weeks of study enrollment. |
ফলাফল
প্রাথমিক ফলাফল ব্যবস্থা
1. Assessment of acne severity [8 week after baseline]
মাধ্যমিক ফলাফলের ব্যবস্থা
1. 2-mm punch biopsy of acne lesion on the EGCG-treated sides [8 week after baseline]
2. Standardized clinical photographs [8 week after baseline]